Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of the Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules

NCT03392402 is registered in ClinicalTrials.gov with Maria Sklodowska-Curie National Research Institute of Oncology as lead sponsor.

NCT NCT03392402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of the Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
Lead sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
December 31, 2020
Enrollment
599 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer, thyroid neoplasm, thyroid nodule